Literature Citations
1. Bioisosteric Ferrocenyl aminoquinoline-benzimidazole Hybrids: Antimicrobial Evaluation and Mechanistic Insights. Baartzes, N., T. Stringer, R. Seldon, D.F. Warner, D. Taylor, S. Wittlin, K. Chibale, and G.S. Smith. European Journal of Medicinal Chemistry, 2019. 180: p. 121-133. PMID[31301563].
[PubMed]. TB_10_2019.
2. Ginger Essential Oil and Fractions against Mycobacterium spp. Baldin, V.P., R. Bertin de Lima Scodro, C.M. Mariano Fernandez, A.L. Ieque, K.R. Caleffi-Ferracioli, V.L. Dias Siqueira, A.L. de Almeida, J.E. Goncalves, D.A. Garcia Cortez, and R.F. Cardoso. Journal of Ethnopharmacology, 2019. 244: 112095. PMID[31325601].
[PubMed]. TB_10_2019.
3. The Synthesis and in Vitro Biological Evaluation of Novel Fluorinated tetrahydrobenzo[j]phenanthridine-7,12-diones against Mycobacterium tuberculosis. Cappoen, D., E. Torfs, T. Meiresonne, P. Claes, E. Semina, F. Holvoet, M.B. de Macedo, F. Cools, T. Piller, A. Matheeussen, K. Van Calster, G. Caljon, P. Delputte, L. Maes, O. Neyrolles, N. De Kimpe, S. Mangelinckx, and P. Cos. European Journal of Medicinal Chemistry, 2019. 181: 111549. PMID[31376569].
[PubMed]. TB_10_2019.
4. Non Nucleoside Reverse Transcriptase Inhibitors, Molecular Docking Studies and Antitubercular Activity of Thiazolidin-4-one Derivatives. Chitre, T.S., S.M. Patil, A.G. Sujalegaonkar, K.D. Asgaonkar, V.M. Khedkar, D.R. Garud, P.C. Jha, S.Y. Gaikwad, S.S. Kulkarni, A. Choudhari, and D. Sarkar. Current Computer-Aided Drug Design, 2019. 15(5): p. 433-444. PMID[30574853].
[PubMed]. TB_10_2019.
5. Integrated Target-based and Phenotypic Screening Approaches for the Identification of Anti-tubercular Agents That Bind to the Mycobacterial Adenylating Enzyme MbtA. Ferguson, L., G. Wells, S. Bhakta, J. Johnson, J. Guzman, T. Parish, R.A. Prentice, and F. Brucoli. ChemMedChem, 2019. 14(19): p. 1735-1741. PMID[31454170]. PMCID[PMC6800809].
[PubMed]. TB_10_2019.
6. Synthesis and Biological Evaluation of Moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-Isatin Hybrids as Potential Anti-tubercular Agents against Both Drug-susceptible and Drug-resistant Mycobacterium tuberculosis Strains. Gao, F., Z. Chen, L. Ma, Y. Fan, L. Chen, and G. Lu. European Journal of Medicinal Chemistry, 2019. 180: p. 648-655. PMID[31352245].
[PubMed]. TB_10_2019.
7. Novel Highly Functionalized 1,4-Naphthoquinone 2-Iminothiazole Hybrids: Synthesis, Photophysical Properties, Crystal Structure, DFT Studies, and Anti(myco)bacterial/Antifungal Activity. Gemili, M., Y. Nural, E. Keles, B. Aydiner, N. Seferoglu, M. Ulger, E. Sahin, S. Erat, and Z. Seferoglu. Journal of Molecular Structure, 2019. 1196: p. 536-546. ISI[000487930600053].
[WOS]. TB_10_2019.
8. 1H-1,2,3-Triazole Tethered Isatin-Moxifloxacin: Design, Synthesis and in Vitro Anti-mycobacterial Evaluation. Jiang, Y., A. Qian, and Y. Li. Archiv der Pharmazie, 2019. 352(7): e1900040. PMID[31106443].
[PubMed]. TB_10_2019.
9. Chemical Synthesis, Molecular Modeling and Pharmacophore Mapping of New Pyrrole Derivatives as Inhibitors of InhA Enzyme and Mycobacterium tuberculosis Growth. Joshi, S.D., S.R.P. Kumar, S. Patil, M. Vijayakumar, V.H. Kulkarni, M.N. Nadagouda, A.M. Badiger, C. Lherbet, and T.M. Aminabhavi. Medicinal Chemistry Research, 2019. 28(11): p. 1838-1863. ISI[000489305700004].
[WOS]. TB_10_2019.
10. A Click Chemistry Approach for the Synthesis of Cyclic Ureido Tethered Coumarinyl and 1-Aza Coumarinyl 1,2,3-triazoles as Inhibitors of Mycobacterium tuberculosis H37RV and their in Silico Studies. Khanapurmath, N., M.V. Kulkarni, S.D. Joshi, and G.N. Anil Kumar. Bioorganic and Medicinal Chemistry, 2019. 27(20): 115054. PMID[31471101].
[PubMed]. TB_10_2019.
11. A Survey of Plants Used to Treat Livestock Diseases in the Mnisi Community, Mpumalanga, South Africa, and Investigation of their Antimicrobial Activity. Khunoana, E.T., B. Madikizela, J.O. Erhabor, S.M. Nkadimeng, L.F. Arnot, I. Van Wyk, and L.J. McGaw. South African Journal of Botany, 2019. 126: p. 21-29. ISI[000489157200004].
[WOS]. TB_10_2019.
12. Phenolic N-Monosubstituted Carbamates: Antitubercular and Toxicity Evaluation of Multi-targeting Compounds. Kratky, M., O. Jandourek, Z. Baranyai, E. Novotna, J. Stolarikova, S. Bosze, and J. Vinsova. European Journal of Medicinal Chemistry, 2019. 181: 111578. PMID[31401536].
[PubMed]. TB_10_2019.
13. Synthesis, Antimicrobial Properties, and Inhibition of Catalase Activity of 1,4-Naphtho- and Benzoquinone Derivatives Containing N-, S-, O-substituted. Kurban, S., N.G. Deniz, C. Sayil, M. Ozyurek, K. Guclu, M. Stasevych, V. Zvarych, O. Komarovska-Porokhnyavet, and V. Novikov. Heteroatom Chemistry, 2019. 2019: 1658417. ISI[000487593000002].
[WOS]. TB_10_2019.
14. C4-Phenylthio beta-Lactams: Effect of the Chirality of the beta-Lactam Ring on Antimicrobial Activity. Kuskovsky, R., D. Lloyd, K. Arora, B.J. Plotkin, J.M. Green, H.I. Boshoff, C. Barry, 3rd, J. Deschamps, and M.I. Konaklieva. Bioorganic and Medicinal Chemistry, 2019. 27(20): 115050. PMID[31474471].
[PubMed]. TB_10_2019.
15. Design, Synthesis, and in Vitro Antimycobacterial Activities of Butylene Tethered 7-Fluoroisatin-Isatin Scaffolds. Liu, B., G.Q. Wang, Y.H. Peng, X.Q. Tang, and G.W. Hu. Journal of Heterocyclic Chemistry. ISI[000490408200001].
[WOS]. TB_10_2019.
16. hERG Optimizations of IMB1603, Discovery of Alternative Benzothiazinones as New Antitubercular Agents. Lv, K., A. Wang, Z. Tao, L. Fu, H. Liu, B. Wang, C. Ma, H. Wang, X. Ma, B. Han, A. Wang, K. Zhang, M. Liu, and Y. Lu. European Journal of Medicinal Chemistry, 2019. 179: p. 208-217. PMID[31254922].
[PubMed]. TB_10_2019.
17. Synthesis, Characterization, Crystal Structure Biological Activity of 4-{2-5-(4-Fluoro-phenyl)-1,3,4 oxadiazol-2-ylsulfanyl-ethyl}-morpholine. Mamatha, S.V., M. Bhat, B.K. Sagar, and S.K. Meenakshi. Journal of Molecular Structure, 2019. 1196: p. 186-193. ISI[000487930600018].
[WOS]. TB_10_2019.
18. Synthesis and Antimicrobial Evaluation of gamma-Borono Phosphonate Compounds in Escherichia coli and Mycobacterium smegmatis. Mancini, G., M. Bouda, J.M. Gamrat, and J.W. Tomsho. ACS Omega, 2019. 4(11): p. 14551-14559. PMID[31528809]. PMCID[PMC6740193].
[PubMed]. TB_10_2019.
19. Isolation and Characterization of Four Terpenoidal Compounds with Potential Antimicrobial Activity from Tarconanthus camphorantus L. (Asteraceae). Osman, W., M. Ibrahim, M. Adam, R. Mothana, M. Mohammed, I. Abdoon, O. Basudan, E. Garelnab, H. Mohamed, B. Osman, and S. Ahmad. Journal of Pharmacy & Bioallied Sciences, 2019. 11(4): p. 373-379. PMID[31619920]. PMCID[PMC6791082].
[PubMed]. TB_10_2019.
20. Novel Pyrazole-containing Compounds Active against Mycobacterium tuberculosis. Poce, G., S. Consalvi, G. Venditti, S. Alfonso, N. Desideri, R. Fernandez-Menendez, R.H. Bates, L. Ballell, D. Barros Aguirre, J. Rullas, A. De Logu, M. Gardner, T.R. Ioerger, E.J. Rubin, and M. Biava. ACS Medicinal Chemistry Letters, 2019. 10(10): p. 1423-1429. PMID[31620228]. PMCID[PMC6792160].
[PubMed]. TB_10_2019.
21. Bengamides Display Potent Activity against Drug-resistant Mycobacterium tuberculosis. Quan, D.H., G. Nagalingam, I. Luck, N. Proschogo, V. Pillalamarri, A. Addlagatta, E. Martinez, V. Sintchenko, P.J. Rutledge, and J.A. Triccas. Scientific Reports, 2019. 9(1): 14396. PMID[31591407]. PMCID[PMC6779907].
[PubMed]. TB_10_2019.
22. Scaffold Morphing to Identify Novel DprE1 Inhibitors with Antimycobacterial Activity. R, M.M., R. Shandil, M. Panda, C. Sadler, A. Ambady, V. Panduga, N. Kumar, J. Mahadevaswamy, M. Sreenivasaiah, A. Narayan, S. Guptha, S. Sharma, V.K. Sambandamurthy, V. Ramachandran, M. Mallya, C. Cooper, K. Mdluli, S. Butler, R. Tommasi, P.S. Iyer, S. Narayanan, M. Chatterji, and P.S. Shirude. ACS Medicinal Chemistry Letters, 2019. 10(10): p. 1480-1485. PMID[31620237]. PMCID[PMC6792157].
[PubMed]. TB_10_2019.
23. In Silico and in Vitro Evaluation of Tetrahydropyridine Compounds as Efflux Inhibitors in Mycobacterium abscessus. Ramis, I.B., J.S. Vianna, L. Silva Junior, A. von Groll, D.F. Ramos, M.M. Lobo, N. Zanatta, M. Viveiros, and P. Silva. Tuberculosis, 2019. 118: 101853. PMID[31430699].
[PubMed]. TB_10_2019.
24. Synthesis and Biological Evaluation of New 4-(4-(1-Benzyl-1H-1,2,3-triazol-4-yl)phenyl)-2-phenylthiazole Derivatives. Shinde, V., P.C. Mhaske, A. Singh, D. Sarkar, and P. Mahulikar. Journal of Heterocyclic Chemistry. ISI[000486847700001].
[WOS]. TB_10_2019.
25. Design of Novel Antimycobacterial Molecule Targeting Shikimate Pathway of Mycobacterium tuberculosis. Sivaranjani, P., V.U. Naik, N.R. Madhulitha, K.S. Kumar, P. Chiranjeevi, S.P. Alexander, and A. Umamaheswari. Indian Journal of Pharmaceutical Sciences, 2019. 81(3): p. 438-447. ISI[000487823400006].
[WOS]. TB_10_2019.
26. Synthesis of Novel (-)-Camphene-based Thiosemicarbazones and Evaluation of anti-Mycobacterium tuberculosis Activity. Souza, M.R.P., N.P. Coelho, V.P. Baldin, R.B.L. Scodro, R.F. Cardoso, C.C. da Silva, and F. Vandresen. Natural Product Research, 2019. 33(23): p. 3372-3377. PMID[29792346].
[PubMed]. TB_10_2019.
27. In Vitro Antibacterial and Cytotoxicity Activities of Tagetes minuta L. Essential Oil Towards Bovine Mastitis Treatment. Sperandio, J., B. Veleirinho, L.A. Honorato, L.H. Campestrini, and S. Kuhnen. Arquivo Brasileiro de Medicina Veterinaria e Zootecnia, 2019. 71(4): p. 1251-1259. ISI[000489552600023].
[WOS]. TB_10_2019.
28. Discovery of Small-molecule Inhibitors Targeting the Ribosomal Peptidyl Transferase Center (PTC) of M. tuberculosis. Tam, B., D. Sherf, S. Cohen, S.A. Eisdorfer, M. Perez, A. Soffer, D. Vilenchik, S.R. Akabayov, G. Wagner, and B. Akabayov. Chemical Science, 2019. 10(38): p. 8764-8767. ISI[000488472900020].
[WOS]. TB_10_2019.
29. In Vitro Efficacies, ADME, and Pharmacokinetic Properties of Phenoxazine Derivatives Active against Mycobacterium tuberculosis. Tanner, L., J.C. Evans, R. Seldon, A. Jordaan, D.F. Warner, R.K. Haynes, C.J. Parkinson, and L. Wiesner. Antimicrobial Agents and Chemotherapy, 2019. 63(11): e01010-01019. PMID[31427302].
[PubMed]. TB_10_2019.
30. N-Trifluoromethylthiolated sulfonimidamides and sulfoximines: Anti-microbial, Anti-mycobacterial, and Cytotoxic Activity. Thota, N., P. Makam, K.K. Rajbongshi, S. Nagiah, N.S. Abdul, A.A. Chuturgoon, A. Kaushik, G. Lamichhane, A.M. Somboro, H.G. Kruger, T. Govender, T. Naicker, and P.I. Arvidsson. ACS Medicinal Chemistry Letters, 2019. 10(10): p. 1457-1461. PMID[31620233]. PMCID[PMC6792286].
[PubMed]. TB_10_2019.
31. Synthesis, Antitubercular Evaluation, Molecular Docking and Molecular Dynamics Studies of 4,6-Disubstituted-2-oxo-dihydropyridine-3-carbonitriles. Verma, R., H.I.M. Boshoff, K. Arora, I. Bairy, M. Tiwari, V.G. Bhat, and G.G. Shenoy. Journal of Molecular Structure, 2019. 1197: p. 117-133. ISI[000487932000014].
[WOS]. TB_10_2019.
32. Identification of Benzothiazinones Containing an Oxime Functional Moiety as New Anti-tuberculosis Agents. Wang, A., K. Lv, Z. Tao, J. Gu, L. Fu, M. Liu, B. Wan, S.G. Franzblau, C. Ma, X. Ma, B. Han, A. Wang, S. Xu, and Y. Lu. European Journal of Medicinal Chemistry, 2019. 181: 111595. PMID[31408806].
[PubMed]. TB_10_2019.
33. Caprazamycins: Biosynthesis and Structure Activity Relationship Studies. Wiker, F., N. Hauck, S. Grond, and B. Gust. International Journal of Medical Microbiology, 2019. 309(5): p. 319-324. PMID[31138496].
[PubMed]. TB_10_2019.
34. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance. Williams, J.T., E.R. Haiderer, G.B. Coulson, K.N. Conner, E. Ellsworth, C. Chen, N. Alvarez-Cabrera, W. Li, M. Jackson, T. Dick, and R.B. Abramovitch. Antimicrobial Agents and Chemotherapy, 2019. 63(10): 300547. PMID[31405862]. PMCID[PMC6761494].
[PubMed]. TB_10_2019.
35. Thienopyrimidinone Derivatives that Inhibit Bacterial tRNA (Guanine37-N-1)-methyltransferase (TrmD) by Restructuring the Active Site with a Tyrosine-flipping Mechanism. Zhong, W.H., K.K. Pasunooti, S. Balamkundu, Y.H. Wong, Q.H. Nah, V. Gadi, S. Gnanakalai, Y.H. Chionh, M.E. McBee, P. Gopal, S.H. Lim, N. Olivier, E.T. Buurman, T. Dick, C.F. Liu, J. Lescar, and P.C. Dedon. Journal of Medicinal Chemistry, 2019. 62(17): p. 7788-7805. ISI[000486361200014].
[WOS]. TB_10_2019.
Patent Citations
This month, no relevant Mycobacterium patents were identified.